United Therapeutic (UTHR) Stock Price, Quote & News

Company Profile

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated wit...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 301 608 9292

Website: www.unither.com

Address:

1000 Spring Street, Silver Spring, United States

clan May. 21 at 2:53 PM

$MNKD 😻 The future for all Mannkind is bright! $SPY $QQQ $UTHR

1 · Reply

Bazzzigar May. 21 at 4:51 AM

$UTHR profit taking continues?

0 · Reply

clan May. 20 at 11:32 PM

$MNKD $UTHR $BX Partners! For a life more humann!

0 · Reply

clan May. 20 at 6:16 PM

$MNKD Resting is over! It's GROW/GO TIME! For the good of all Mannkind! $UTHR $IBB #RALDPI #Afrezza

0 · Reply

msgu1021 May. 20 at 10:45 AM

$LQDA Wow!😮 Love to see this one beat $UTHR market cap sooner than later. Is it too much to ask for?

1 · Reply

grampslol May. 19 at 12:30 PM

Pennyland $MNKD 592 total employees 292 employees classified as sales, general and administrative 31 Vice Presidents 225 executive directors, senior managers and directors ... Top heavy Csuite Flop drug Coughing issues identified by partner $UTHR so they're moving on to SMI and Nebulizer

1 · Reply

mikesterz7 May. 19 at 1:12 AM

$UTHR Tyvaso is already approved for a different lung condition, but it is still considered experimental for idiopathic pulmonary fibrosis. The company plans to ask the FDA for priority review of an expanded approval by the end of this summer.

0 · Reply

StocktwitsNews May. 19 at 12:02 AM

UTHR Holds As Tyvaso Shows 33% Lower Worsening Risk In Rare Lung Scarring Disease $UTHR $MNKD $IJH https://stocktwits.com/news/equity/markets/uthr-holds-as-tyvaso-shows-33-percent-lower-worsening-risk-in-rare-lung-scarring-disease/cZXuEwqRemH

1 · Reply

clan May. 18 at 9:30 PM

$MNKD $UTHR 🙂 More hubbub. Bridge study w/b more hubbub.

0 · Reply

MrMulally May. 18 at 8:22 PM

$MNKD $UTHR

1 · Reply

United Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026

2026-05-18T20:21:29.000Z - 3 days ago

United Therapeutics says TETON-1 study published in NEJM

May 18, 2026, 4:15 PM EDT - 3 days ago

United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026

May 17, 2026, 2:15 PM EDT - 4 days ago

United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026

2026-05-15T22:05:52.000Z - 6 days ago

United Therapeutics cleared by FDA to proceed with UHeart clinical trial

May 15, 2026, 6:00 PM EDT - 6 days ago

United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial

2026-05-13T10:10:51.000Z - 8 days ago

United Therapeutics, Varda Space Industries team on use of microgravity

May 12, 2026, 7:00 AM EDT - 9 days ago

United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference

2026-05-11T11:20:41.000Z - 10 days ago

United Therapeutics to present positive data of treprostinil in IPF

May 11, 2026, 6:30 AM EDT - 10 days ago

United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026

2026-05-07T19:01:05.000Z - 14 days ago

United Therapeutics price target lowered to $516 from $519 at Morgan Stanley

2026-05-07T12:19:06.000Z - 14 days ago

United Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo

2026-05-07T11:42:13.000Z - 14 days ago

United Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo

2026-05-07T09:22:42.000Z - 14 days ago

United Therapeutics reports Q1 EPS $5.82, consensus $6.86

2026-05-07T09:21:34.000Z - 14 days ago

United Therapeutics reports Q1 EPS $5.82, consensus $6.86

May 6, 2026, 9:00 AM EDT - 15 days ago

United Therapeutics Earnings Call Transcript: Q1 2026

May 6, 2026, 9:00 AM EDT - 15 days ago

United Therapeutics Quarterly report: Q1 2026

May 6, 2026, 9:00 AM EDT - 15 days ago

United Therapeutics Earnings release: Q1 2026

May 6, 2026, 9:00 AM EDT - 15 days ago

United Therapeutics Slides: Q1 2026

May 6, 2026, 6:30 AM EDT - 15 days ago

United Therapeutics Corporation Reports First Quarter 2026 Financial Results

2026-04-29T13:08:31.000Z - 22 days ago

United Therapeutics announces retirement of Professor Dwek from board

Apr 29, 2026, 8:00 AM EDT - 22 days ago

United Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 22 days ago

United Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 7:00 AM EDT - 22 days ago

United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors

Apr 22, 2026, 7:00 AM EDT - 4 weeks ago

United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026

Apr 20, 2026, 6:30 AM EDT - 4 weeks ago

United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026

2026-04-10T12:57:05.000Z - 5 weeks ago

United Therapeutics price target raised to $519 from $471 at Morgan Stanley

2026-04-10T09:40:13.000Z - 5 weeks ago

United Therapeutics initiated with an Outperform at Raymond James

2026-04-09T20:31:09.000Z - 6 weeks ago

United Therapeutics initiated with an Outperform at Raymond James

2026-04-08T11:16:05.000Z - 6 weeks ago

United Therapeutics announces FDA granted RMAT designation to miroliverELAP

Apr 8, 2026, 7:00 AM EDT - 6 weeks ago

United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure

2026-04-07T15:03:10.000Z - 6 weeks ago

United Therapeutics price target raised to $700 from $643 at RBC Capital

2026-03-31T14:43:37.000Z - 7 weeks ago

United Therapeutics price target raised to $660 from $600 at H.C. Wainwright

Mar 30, 2026, 7:00 AM EDT - 7 weeks ago

United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2

Mar 11, 2026, 6:14 PM EDT - 2 months ago

United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine

Mar 9, 2026, 1:00 PM EDT - 2 months ago

United Therapeutics Transcript: Leerink Global Healthcare Conference 2026

Mar 9, 2026, 7:00 AM EDT - 2 months ago

United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program

Mar 3, 2026, 7:00 AM EST - 2 months ago

United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference

Mar 2, 2026, 2:30 PM EST - 2 months ago

United Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 8:30 AM EST - 2 months ago

United Therapeutics Transcript: Study result

Mar 2, 2026, 8:30 AM EST - 2 months ago

United Therapeutics Press release: Study result

Mar 2, 2026, 8:30 AM EST - 2 months ago

United Therapeutics Slides: Study result

Mar 2, 2026, 6:38 AM EST - 2 months ago

United Therapeutics' blood pressure drug meets main, secondary goals in late-stage study

Mar 2, 2026, 6:30 AM EST - 2 months ago

United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy

Feb 25, 2026, 9:00 AM EST - 3 months ago

United Therapeutics Earnings Call Transcript: Q4 2025

Feb 25, 2026, 9:00 AM EST - 3 months ago

United Therapeutics Earnings release: Q4 2025

Feb 25, 2026, 9:00 AM EST - 3 months ago

United Therapeutics Annual report: Q4 2025

Feb 25, 2026, 9:00 AM EST - 3 months ago

United Therapeutics Slides: Q4 2025

Feb 25, 2026, 6:30 AM EST - 3 months ago

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 23, 2026, 7:00 AM EST - 3 months ago

United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference

Feb 11, 2026, 7:00 AM EST - 3 months ago

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026

Jan 26, 2026, 7:00 AM EST - 4 months ago

United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure

Jan 22, 2026, 7:00 AM EST - 4 months ago

United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors

Jan 12, 2026, 4:30 PM EST - 4 months ago

United Therapeutics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 4:30 PM EST - 4 months ago

United Therapeutics Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 3:57 PM EST - 4 months ago

6 stocks and ETFs that these unsung market heroes see outperforming in 2026

AAPL DT GLD ITRN MNKD NVDA OMC

Jan 5, 2026, 7:00 AM EST - 4 months ago

United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 3, 2025, 7:19 AM EST - 6 months ago

Flurry of Bullish Inflows Sends United Therapeutics Higher

Nov 18, 2025, 7:00 AM EST - 6 months ago

United Therapeutics Transcript: Jefferies London Healthcare Conference 2025

Nov 10, 2025, 9:30 AM EST - 6 months ago

United Therapeutics Transcript: UBS Global Healthcare Conference 2025

Nov 4, 2025, 7:00 AM EST - 7 months ago

United Therapeutics Corporation to Present at Upcoming Investor Conferences

Nov 3, 2025, 7:00 AM EST - 7 months ago

United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease

Oct 29, 2025, 9:00 AM EDT - 7 months ago

United Therapeutics Earnings Call Transcript: Q3 2025

Oct 29, 2025, 9:00 AM EDT - 7 months ago

United Therapeutics Earnings release: Q3 2025

Oct 29, 2025, 9:00 AM EDT - 7 months ago

United Therapeutics Quarterly report: Q3 2025

Oct 29, 2025, 9:00 AM EDT - 7 months ago

United Therapeutics Slides: Q3 2025

Oct 29, 2025, 6:30 AM EDT - 7 months ago

United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results

Oct 15, 2025, 7:00 AM EDT - 7 months ago

United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025

Oct 13, 2025, 7:00 AM EDT - 7 months ago

United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting

Sep 28, 2025, 12:30 PM EDT - 8 months ago

United Therapeutics Transcript: Study Update

Sep 28, 2025, 12:30 PM EDT - 8 months ago

United Therapeutics Press release: Study Update

Sep 28, 2025, 12:30 PM EDT - 8 months ago

United Therapeutics Slides: Study Update

Sep 23, 2025, 1:10 PM EDT - 8 months ago

United Therapeutics Transcript: Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

Sep 19, 2025, 7:00 AM EDT - 8 months ago

United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis

Sep 16, 2025, 7:00 AM EDT - 8 months ago

United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum

Sep 12, 2025, 7:00 AM EDT - 8 months ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress

Sep 8, 2025, 3:20 PM EDT - 9 months ago

United Therapeutics Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 3, 2025, 10:10 AM EDT - 9 months ago

United Therapeutics: Is UTHR Stock Still A Buy At $400?

Sep 2, 2025, 10:09 AM EDT - 9 months ago

United Therapeutics surges as Tyvaso succeeds in IPF trial: should you invest?

Sep 2, 2025, 9:17 AM EDT - 9 months ago

United Therapeutics shares surge on successful late-stage lung disease study

Sep 2, 2025, 7:00 AM EDT - 9 months ago

United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis

Aug 29, 2025, 7:00 AM EDT - 9 months ago

United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 1, 2025, 7:00 AM EDT - 10 months ago

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program

Jul 30, 2025, 9:00 AM EDT - 10 months ago

United Therapeutics Earnings Call Transcript: Q2 2025

Jul 30, 2025, 9:00 AM EDT - 10 months ago

United Therapeutics Quarterly report: Q2 2025

Jul 30, 2025, 9:00 AM EDT - 10 months ago

United Therapeutics Earnings release: Q2 2025

Jul 30, 2025, 9:00 AM EDT - 10 months ago

United Therapeutics Slides: Q2 2025

Jul 30, 2025, 6:30 AM EDT - 10 months ago

United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results

Jul 16, 2025, 7:00 AM EDT - 11 months ago

United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025

Jun 24, 2025, 7:00 AM EDT - 11 months ago

United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver

Jun 23, 2025, 7:00 AM EDT - 11 months ago

United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension

May 2, 2025, 7:16 AM EDT - 1 year ago

The Top 3 Stock Picks at the World's Greatest Hedge Fund

NVO PLTR

Apr 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Earnings Call Transcript: Q1 2025

Apr 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Earnings release: Q1 2025

Apr 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Quarterly report: Q1 2025

Apr 30, 2025, 9:00 AM EDT - 1 year ago

United Therapeutics Slides: Q1 2025

Apr 30, 2025, 6:30 AM EDT - 1 year ago

United Therapeutics Corporation Reports First Quarter 2025 Financial Results

Apr 29, 2025, 8:00 AM EDT - 1 year ago

United Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

United Therapeutics Proxy statement: Proxy Filing

Apr 21, 2025, 7:00 AM EDT - 1 year ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference

Apr 4, 2025, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions

Mar 11, 2025, 10:00 AM EDT - 1 year ago

United Therapeutics Transcript: Leerink’s Global Healthcare Conference 2025

Mar 4, 2025, 7:00 AM EST - 1 year ago

United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025

Mar 3, 2025, 1:50 PM EST - 1 year ago

United Therapeutics Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 26, 2025, 9:00 AM EST - 1 year ago

United Therapeutics Earnings Call Transcript: Q4 2024

Feb 26, 2025, 9:00 AM EST - 1 year ago

United Therapeutics Earnings release: Q4 2024

Feb 26, 2025, 9:00 AM EST - 1 year ago

United Therapeutics Annual report: Q4 2024

Feb 26, 2025, 9:00 AM EST - 1 year ago

United Therapeutics Slides: Q4 2024

Feb 26, 2025, 6:30 AM EST - 1 year ago

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 24, 2025, 7:00 AM EST - 1 year ago

United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference

Feb 19, 2025, 7:00 AM EST - 1 year ago

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025

clan May. 21 at 2:53 PM

$MNKD 😻 The future for all Mannkind is bright! $SPY $QQQ $UTHR

1 · Reply

Bazzzigar May. 21 at 4:51 AM

$UTHR profit taking continues?

0 · Reply

clan May. 20 at 11:32 PM

$MNKD $UTHR $BX Partners! For a life more humann!

0 · Reply

clan May. 20 at 6:16 PM

$MNKD Resting is over! It's GROW/GO TIME! For the good of all Mannkind! $UTHR $IBB #RALDPI #Afrezza

0 · Reply

msgu1021 May. 20 at 10:45 AM

$LQDA Wow!😮 Love to see this one beat $UTHR market cap sooner than later. Is it too much to ask for?

1 · Reply

grampslol May. 19 at 12:30 PM

1 · Reply

mikesterz7 May. 19 at 1:12 AM

0 · Reply

StocktwitsNews May. 19 at 12:02 AM

1 · Reply

clan May. 18 at 9:30 PM

$MNKD $UTHR 🙂 More hubbub. Bridge study w/b more hubbub.

0 · Reply

MrMulally May. 18 at 8:22 PM

$MNKD $UTHR

1 · Reply

grampslol May. 17 at 11:03 PM

$MNKD is afizzle... missed quarterly earnings and revenue... caveat emptor... Permapenny...Inhaled insulin = epic flop...black box label... $UTHR found soft mist is the future ... #tradeforpennies

0 · Reply

cykuTYTkaxa May. 17 at 10:23 PM

$UTHR’s next frontier may arrive sooner than the market expects: the 3D-printed “U-Lung,” powered by the advanced bioprinting platform of 3D Systems. A transformative convergence of regenerative medicine, engineering, and scalable organ innovation.

0 · Reply

AlertsAndNews May. 17 at 10:09 PM

$UTHR United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026 "study met its primary endpoint, with ralinepag achieving a statistically significant 55% reduction in risk of clinical worsening in predominantly pre-treated patients with pulmonary arterial hypertension."

1 · Reply

clan May. 17 at 10:01 PM

$MNKD $UTHR Type 1 diabetic, user of inhalable mealtime insulin Afrezza, and Indycar driver, Conor Daly, will start the Indianapolis 500 🏁🏎🥛 next week on row 3. Go #23! For the good of all Mannkind. $LLY $NVO $SNY

0 · Reply

grampslol May. 16 at 2:34 PM

Things looking pennyland for Afizzle company $MNKD $UTHR

0 · Reply

clan May. 16 at 2:06 PM

$MNKD $UTHR $BX Things are looking up for mankind, Mannkind and MNKD! Follow the pros...↗️

1 · Reply

clan May. 16 at 12:00 PM

$JNJ $IBB For abt $40B, might JNJ swoop in and acquire both $UTHR and $MNKD at the same time? It would be for the good of all Mannkind.

0 · Reply

clan May. 16 at 10:54 AM

$MNKD $UTHR 👀 Look closely. 💪 When you see it, you will know. 😲 @DRFSR @stevemano @rooksleanne @chazbruin2 @ItzaFugazi @masspd 🏁🏎🥛

2 · Reply

Outcomes May. 15 at 10:15 PM

$MNKD $UTHR https://ir.unither.com/press-releases/2026/05-15-2026-230017490

1 · Reply

Bazzzigar May. 15 at 3:47 PM

$UTHR more drop ahead

0 · Reply

JFais May. 13 at 6:55 PM

Finished DD on new Playbook setup, now moving on to $MNKD on current pullback after $UTHR ralinepag DPI collab announced Still upset they acquired my $SCPH shares on the cheap (Furoscix autoinjector with July 26 PDUFA date, $500M+ opportunity)

0 · Reply

Gambaa May. 13 at 10:42 AM

$UTHR space drugs! 🤡🤡🤡

1 · Reply

Market Cap	24.06B
Revenue (ttm)	3.18B
Net Income (ttm)	1.33B
EPS (ttm)	N/A
PE Ratio	20.93
Forward PE	20.95
Profit Margin	41.94%
Debt to Equity Ratio	0.00

Volume	420,800
Avg Vol	545,552
Day's Range	N/A - N/A
Shares Out	42.45M
Stochastic %K	15%
Beta	0.60
Analysts	Strong Sell
Price Target	$666.92